UCB
Donatello Crocetta MD MBA currently serves as the Global Head of Medical Affairs at UCB, leading a team of medical professionals to develop strategic medical initiatives across a diverse product portfolio. With extensive experience in the pharmaceutical industry, Donatello previously held senior roles at Takeda, Shire, and Alnylam Pharmaceuticals, overseeing medical affairs strategies for multiple therapeutic areas, including rare diseases and immunology, and successfully launching innovative therapies globally. An accomplished leader with an Executive MBA and a Doctor of Medicine, Donatello is well-versed in medical strategy, market access, and operational excellence, having built high-performing teams and integrated medical organizations throughout their career.
This person is not in any teams
This person is not in any offices
UCB
47 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.